Prevalence of Metabolic Syndrome in Newly Diagnosed Psoriasis Patients: A Case Control Study from a Tertiary Care Hospital in Assam
Journal Title: International Journal of Health Sciences and Research - Year 2017, Vol 7, Issue 10
Abstract
Background: Psoriasis is a chronic inflammatory and proliferative condition of the skin, characterized by scaly, sharply demarcated, indurated plaques, present particularly over extensor surfaces and scalp. Metabolic syndrome is a cluster of risk factors including central obesity, dyslipidemia, hypertension and glucose intolerance, and is a strong predictor of cardiovascular diseases, diabetes and stroke. Recent studies have shown that the prevalence of metabolic syndrome in psoriasis is significantly elevated. Aim: To evaluate the prevalence of metabolic syndrome among newly diagnosed psoriasis patients. Methods: The study comprised sixty new cases of psoriasis patients attending the outpatient of Department of Dermatology and Venereology from June 2012 to May 2013 and sixty healthy individuals as controls. Venous samples were taken at the first visit after the subjects had fasted overnight (at least 8 hours). Plasma glucose and lipid profile were estimated. Waist circumference and blood pressure were recorded. Participants with 3 or more criteria were defined as having metabolic syndrome according to South Asian Modified National Cholesterol Education Program Adult Treatment Panel III. Results: In the psoriasis group, 16(26.66%) patients had metabolic syndrome, where as in the control group only 5 (8.33%) had metabolic syndrome, which showed a significant association with P= 0.016. Conclusion: There was a significantly higher prevalence of metabolic syndrome in patients with psoriasis, which could play a relevant role in accelerating atherosclerosis. The association was not limited to severe cases but also occurs with mild cases. Therefore, the study emphasized the fact that for the better management and to prevent the future risk of cardiovascular complications, all patients must be screened for cardiovascular risk factors at the disease onset, irrespective of the severity of psoriasis. All patients with psoriasis should be encouraged to correct aggressively their modifiable cardiovascular risk factors.
Authors and Affiliations
Prof. Debeeka Hazarika
Keywords
Related Articles
- EP ID EP379137
- DOI -
- Views 68
- Downloads 0
Immature Teratoma with Gliomatosis Peritonei: A Rare Case Report
The aim of reporting this unusual case is to identify mature glial tissue deposits in the peritoneum in a case of immature teratoma of right ovary; a diagnostic challenge for a neophyte in pathology. We report a case of...
Interictal Psychiatric Comorbidity in Patients with Epilepsy
Epilepsy is a neurological disorder with a life time prevalence of one percent. Psychiatric comorbidities are relatively frequent in people with epilepsy. Population-based studies have identified a lifetime prevalence of...
Effectiveness of School-Based, Peer-Led Sexual Health Interventions in Increasing STIS/HIV Knowledge amongst Adolescents: A Systematic Review
Background: The spread of sexually transmitted infections (STIs) including HIV and early pregnancy among adolescents have become public health problems in many settings. School-based, peer-led sexual health education aim...
Use of WHODAS 2.0 in Tinnitus Patients: Correlating Results with THI
The World Health Organization’s (WHO) Disability Assessment Schedule (WHODAS 2.0) is a generic health status instrument developed from a comprehensive set of items related to ‘Activity’ and ‘Participation’ component of W...
Therapeutic Efficacy of Munzij wa Mushil-E-Balgham (Poly Herbal Formulation) and Dalk (Massage) with Roghan-E-Farfiyun in the Management of Irqunnasa (Sciatica): An Open Labelled Clinical Trial
Sciatica is the pain that originates deep in the buttock and radiates towards the posterolateral thigh; may continue to the calf, medial malleolus (L4), lateral malleolus (L5) or heel (S1). In Unani system of medicine, I...